Video Experimental Relacionado
Updated: Jul 14, 2026
07:51
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
Reacciones idiosincrásicas al fármaco: los síndromes del metabolito reactivo
S R Knowles1, J Uetrecht, N H Shear
1Department of Medicine, Sunnybrook & Women's College Health Sciences Centre, University of Toronto, Ontario, Canada.
Lancet (London, England)
|November 15, 2000
Resumen
Las reacciones farmacológicas idiosincrásicas son eventos adversos impredecibles y graves. Una mayor investigación sobre su fisiopatología es crucial para desarrollar mejores estrategias de diagnóstico y tratamiento.
Área de la Ciencia:
- Farmacología Farmacología.
- Toxicología Toxicología.
- Inmunología Inmunología.
Sus antecedentes:
- Las reacciones farmacológicas idiosincrásicas (RDA) son eventos adversos impredecibles con una morbilidad y mortalidad significativas.
- Las IDR graves a menudo se presentan con fiebre y daño a los órganos internos.
- Los mecanismos exactos que causan las IDR siguen siendo poco conocidos, a pesar de la identificación de metabolitos reactivos.
Objetivo del estudio:
- Para resaltar la necesidad de una mayor investigación sobre la fisiopatología de las reacciones idiosincrásicas a los fármacos.
- Hacer hincapié en la importancia de establecer un consenso sobre las definiciones y mejorar la presentación de informes para obtener datos epidemiológicos fiables.
- Para subrayar el objetivo de desarrollar mejores pruebas de diagnóstico y tratamientos para las IDR.
Principales métodos:
- Revisión de la comprensión actual de los mecanismos idiosincrásicos de reacción al fármaco.
- Análisis de los desafíos en la definición y presentación de informes de IDR.
- Identificación de las brechas de investigación en fisiopatología.
Principales resultados:
- Se ha avanzado en la identificación de metabolitos reactivos, pero los mecanismos subyacentes son escurridizos.
- La falta de consenso en las definiciones lleva a datos epidemiológicos poco fiables.
- Los conocimientos actuales son insuficientes para desarrollar herramientas diagnósticas y terapéuticas efectivas.
Conclusiones:
- Es esencial una mayor investigación sobre la fisiopatología de los IDR.
- Se necesitan definiciones estandarizadas y informes mejorados para una epidemiología precisa.
- Avanzar en la comprensión de los IDR facilitará el desarrollo de mejores métodos de diagnóstico y tratamiento.
Videos de Conceptos Relacionados
01:17Drug Metabolism: Phase I Reactions
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
01:14Drug Metabolism: Phase II Reactions
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...